+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Polymyositis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Polymyositis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 68 Pages
  • Global
From
Dry Eye Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dry Eye Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 151 Pages
  • Global
From
Alzheimer's Disease (AD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Alzheimer's Disease (AD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 157 Pages
  • Global
From
From
Aplastic Anemia - Epidemiology Forecast - 2034 - Product Thumbnail Image

Aplastic Anemia - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
Liver Cirrhosis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Liver Cirrhosis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
From
Antiphospholipid Syndrome (APS) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Antiphospholipid Syndrome (APS) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 79 Pages
  • Global
From
Chronic Heart Failure - Epidemiology Forecast - 2034 - Product Thumbnail Image

Chronic Heart Failure - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 165 Pages
  • Global
From
Helicobacter Pylori Infections - Epidemiology Forecast - 2034 - Product Thumbnail Image

Helicobacter Pylori Infections - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 90 Pages
  • Global
From
Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 84 Pages
  • Global
From
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 69 Pages
  • Global
From
Osteogenesis Imperfecta (OI) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Osteogenesis Imperfecta (OI) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 57 Pages
  • Global
From
Myotonic Dystrophy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myotonic Dystrophy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 105 Pages
  • Global
From
Parainfluenza Virus Infection - Epidemiology Forecast - 2034 - Product Thumbnail Image

Parainfluenza Virus Infection - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 60 Pages
  • Global
From
Prader-Willi Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Prader-Willi Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 80 Pages
  • Global
From
Stargardt Disease (STGD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Stargardt Disease (STGD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 66 Pages
  • Global
From
Dermatomyositis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dermatomyositis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 110 Pages
  • Global
From
From
Mild Cognitive Impairment - Epidemiology Forecast - 2034 - Product Thumbnail Image

Mild Cognitive Impairment - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 106 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more